New blood cancer NHS treatment could help hundreds of people

New blood cancer NHS treatment could help hundreds of people

A new treatment for Hodgkin lymphoma has been recommended for routine use on the NHS. Around 800 people with the advanced form of blood cancer could benefit, it is believed.

First drug backed for NHS use in untreated Hodgkin lymphoma

Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated late-stage Hodgkin lymphoma.

First-ever NHS treatment approved for advanced Hodgkin lymphoma

New combination therapy will be available on the NHS, offering new hope to people with advanced Hodgkin lymphoma From the 2nd April 2025, adults with advanced Hodgkin lymphoma will have access to a new treatment called brentuximab vedotin (brand name Adcetris) combined with other therapies. Hodgkin lymphoma is a type of cancer that affects cells in the lymphatic system. Advanced (stage 3 and 4) CD30-positive Hodgkin lymphoma most commonly affect…

Hodgkin lymphoma update as new treatment could help 800 people

The National Institute for Health and Care Excellence has made a recommendation

New treatment for advanced blood cancer recommended for use on NHS

It is estimated that about 800 people with Hodgkin lymphoma could benefit from the decision by the National Institute for Health and Care Excellence. A new treatment for an advanced form of blood cancer has been recommended for routine NHS use. It is estimated that about 800 people with Hodgkin lymphoma – which develops in the lymphatic system, a network of vessels and glands throughout the body – could benefit from the decision by the National …

Recently, I feel like I've been seeing more and more news on the internet about leukemia. You might have the impression that it's something that young people get, but in adults, like other cancers, the incidence increases with age, so it's not something that affects young people...